Preclinical systematic review & meta-analysis of cyclosporine for the treatment of myocardial ischemia-reperfusion injury

BACKGROUND: Though best known for its immunosuppressant effects, cyclosporine A (CsA) has also been studied as a treatment to mitigate ischemia-reperfusion injury (IRI) by its inhibition of the mitochondria permeability transition pore (mPTP). Despite numerous preclinical studies supporting its bene...

Descripción completa

Detalles Bibliográficos
Autores principales: Hefler, Joshua, Marfil-Garza, Braulio A., Campbell, Sandra, Freed, Darren H., Shapiro, A. M. James
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9577743/
https://www.ncbi.nlm.nih.gov/pubmed/36267756
http://dx.doi.org/10.21037/atm-22-618

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9577743/
https://www.ncbi.nlm.nih.gov/pubmed/36267756
http://dx.doi.org/10.21037/atm-22-618

Ejemplares similares